XenoPort Inc. - Articles and news items

GlaxoSmithKline logo

GSK and XenoPort receive FDA approval for Horizant® for postherpetic neuralgia

Industry news, News / 7 June 2012 / GlaxoSmithKline

The US FDA has approved Horizant® (gabapentin enacarbil)…

GlaxoSmithKline logo

Regulatory update: GSK and XenoPort submit supplemental new drug application to FDA

Industry news, News / 9 August 2011 / GlaxoSmithKline

GSK and XenoPort, Inc. request approval of Horizant™…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+